Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNAI3 | P08754 | 5/20 | 0.63 |
| ▸ | GNAO1 | P09471 | 5/20 | 0.63 |
| ▸ | GNAI1 | P63096 | 5/20 | 0.63 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.62 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9292459 | 0.98 | GNAI3 (0.67) | GNAI3GNAO1GNAI1ALOX15KDM4E | |
| SCHEMBL4392829 | 0.93 | ALOX15 (0.65) | GNAI3GNAO1GNAI1ALOX15SIGMAR1 | |
| SCHEMBL6277287 | 0.91 | GNAI3 (0.63) | GNAI3GNAO1GNAI1ALOX15 | |
| SCHEMBL4944738 | 0.91 | GNAI3 (0.63) | GNAI3GNAO1GNAI1 | |
| SCHEMBL35895 | 0.87 | — | — | |
| SCHEMBL250855 | 0.87 | GNAI3 (0.70) | GNAI3GNAO1GNAI1SIGMAR1KDM4E | |
| SCHEMBL1043043 | 0.87 | GNAI3 (0.70) | GNAI3GNAO1GNAI1SIGMAR1KDM4E | |
| SCHEMBL4389217 | 0.86 | GNAI3 (0.57) | GNAI3GNAO1GNAI1ALOX15SIGMAR1 | |
| SCHEMBL18630997 | 0.85 | GNAI3 (0.74) | GNAI3GNAO1GNAI1SIGMAR1KDM4E | |
| SCHEMBL1043024 | 0.85 | GNAI3 (0.74) | GNAI3GNAO1GNAI1SIGMAR1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2004244376-A | METHOD FOR PRODUCING AMINOETHYLARYLPIPERAZINE DERIVATIVE | NISSAN CHEM IND LTD | 2004-09-02 | — | — | JP | disclosed |
| US-6344458-B1 | CENTRAL NERVOUS SYSTEM DISORDERS | AMERICAN HOME PRODUCTS CORPORATION | 2002-02-05 | — | — | US | disclosed |
| EP-1140882-A1 | PIPERAZINE ETHYLAMIDE DERIVATIVES WITH 5-HT1A RECEPTOR ACTIVITY | AMERICAN HOME PRODUCTS CORPORATION (US) | 2001-10-10 | — | — | EP | disclosed |
| WO-2000035892-A1 | PIPERAZINE ETHYLAMIDE DERIVATIVES WITH 5-HT1A RECEPTOR ACTIVITY | AMERICAN HOME PRODUCTS CORPORATION (US) | 2000-06-22 | — | — | WO | disclosed |
| EP-0647222-A1 | N(HETERO)-ARYL-N(HETERO)-TETRALIN-ALKYL-PIPERAZINE HAVING SEROTONINERGIC, DOPAMINERGIC AND ADRENERGIC ACTIVITY | PHARMACIA & UPJOHN S.p.A. (IT) | 1995-04-12 | — | — | EP | disclosed |
| WO-1994000441-A1 | N(HETERO)-ARYL-N(HETERO)-TETRALIN-ALKYL-PIPERAZINE HAVING SEROTONINERGIC, DOPAMINERGIC AND ADRENERGIC ACTIVITY | FARMITALIA CARLO ERBA S.R.L. (IT) | 1994-01-06 | — | — | WO | disclosed |
| US-4721715-A | Derivatives of 4-(arylpiperazinyl-ethylaminoethoxy) phenol useful for effecting hypolipidemic therapy or cardiovascular therapy | SOCIETE CORTIAL, S.A. (FR) | 1988-01-26 | — | — | US | disclosed |